Role of topical brinzolamide in infantile nystagmus syndrome
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Patients of infantile nystagmus syndrome will be included.
- Registration Number
- CTRI/2018/05/014335
- Lead Sponsor
- Pharmacology department RPC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 29
Inclusion Criteria
1.Informed consent from self or guardian(in case of minor)
2.Subjects will have INS diagnosed by clinical evaluation and eye movement recordings
3.will be >=10 years of age
4.will able to make the required study visits.
Exclusion Criteria
1.Current or within the last 12 months use of medications for nystagmus, history of any ocular surgery.
2.Any systemic diseases requiring medication known to affect the ocular motor system
3.Behavioural or neurological disorders which would interfere with the study
4.Pregnancy,nursing or planning of a pregnancy and
5.Known allergy to brinzolamide
6.Participation in any study involving an investigational new drug within the past year
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method